RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Chemical Industry

A collection of news and information related to Chemical Industry published by this site and its partners.

Top Chemical Industry Articles

Displaying items 56-66
  • Clean Energy Challenge aims to prove there's money in being green

     Clean Energy Challenge aims to prove there's money in being green
    That sign in your hotel room that suggests reusing your towel to help the environment? Gary Eden wants to make it a relic of the past. "We've all been putting thousands of tons of chlorine containing chemicals into our water," said Eden, president of EP...
  • Toxic emission spikes at fracking sites are rarely monitored, study finds

    People in natural gas drilling areas who complain about nauseating odors, nosebleeds and other symptoms they fear could be caused by shale development are usually told by state regulators that monitoring data show the air quality is fine. But a new study...
  • Medicare pays hundreds of millions to Maryland providers

    Medicare pays hundreds of millions to Maryland providers
    Eye specialists, ambulance service providers and clinical laboratories are the biggest recipients of Medicare payments around the country and in Maryland, taking in hundreds of millions of dollars from the federal health program for seniors, according...
  • Dietary supplements: The deadly toll of deregulation

    Dietary supplements: The deadly toll of deregulation
    Here's the bad news: A dietary supplement named OxyElite Pro is still apparently making people sick, more than a year after the Hawaii Department of Health was alerted to seven cases of acute hepatitis and liver failure among its users. As of last...
  • A call for help — and an epic fail — in West Boca

    It happened again. Family members say someone in the midst of a mental health crisis dialed 911 seeking help. Matthew Pollow, 28, got a death sentence instead. That's the blunt way to describe the events of last Wednesday at a West Boca apartment...
  • Lupin name on Baltimore building marks drug company's expansion

    Lupin name on Baltimore building marks drug company's expansion
    Lupin Pharmaceuticals, Inc. has placed its name in lights over the Inner Harbor, a mark of the Indian drug manufacturer's growing presence since the company located its U.S. headquarters in Baltimore more than a decade ago. Lupin, which today sells...
  • Growing interest in STEM [Commentary]

    Growing interest in STEM [Commentary]
    The dearth of women and certain minorities in Science, Technology, Engineering and Mathematics (STEM) fields represents a huge problem within this country and is a crisis often repeated in the news today. These stories often provide the same problem and,...
  • Diabetes expenses have decreased, but are still high

    NEW YORK (Reuters Health) - Out-of-pocket expenses for diabetes treatment have gone down for many U.S. patients over the past decade, according to a new study. But nearly a quarter of people with diabetes still face high expenses. In particular, "(out-...
  • Hotel chain La Quinta makes subdued debut in crowded IPO market

    (Reuters) - Shares of Blackstone-backed hotel chain La Quinta Holdings Inc made a subdued market debut as investors took the view that the stock was fully priced in a crowded IPO market. La Quinta's shares, which priced below the expected range at $17,...
  • WHO joins clamor to make new hepatitis C pills affordable

    LONDON (Reuters) - The World Health Organization wants a "concerted effort" to drive down the cost of new hepatitis C drugs that offer a cure for the liver-destroying virus but are unaffordable for most infected people worldwide. The forthright...
  • India's Sun Pharma plans gradual phase-out of Ranbaxy-branded drugs in U.S.: sources

    MUMBAI (Reuters) - India's Sun Pharmaceutical Industries Ltd plans to begin phasing out sales of generic drugs branded as Ranbaxy Laboratories Ltd products in the United States, after completing a $3.2 billion takeover of its loss-making rival by the year...